Month: October 2020
-
Better Precision Medicine Outcomes Shown for Leukemia
Clinical trial results show a strategy that first tests for genomic mutations to guide treatments results in better outcomes for patients with acute myeloid leukemia.
-
Lilly, NIH Halt Covid-19 Antibody Therapy Trial
Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients.
-
Think About Your Real Business Needs
One of the most important things that you have to consider is whether a decision you make is based on what you want or what your business needs.
-
Bayer Gains Gene Therapy Biotech in $4B Deal
Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders.
-
Precision Drug Trial Shows Solid Tumor Shrinkage
Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types.
-
Should We Buy Electric Vehicles?
Now the advantages are clear for everyone to see, and the charging stations are beginning to increase.
-
Infographic – Covid-19 Cases Reach New Highs
New Covid-19 infection cases are surging again in most parts of the world, with numbers accelerating fastest in Europe and the Americas.
-
Phone Video Algorithm Screens for Stroke
A medical informatics team designed a computer model from patient videos to help emergency room physicians quickly diagnose stroke.
-
Start-Up Developing Engineered B-Cell Therapies
A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system.
-
Roche Gains Covid-19 Oral Drug Candidate
Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a oral drug, rather than an infusion.